Borderline Ankle-Brachial Index Value of 0.91–0.99 Is Associated With Endothelial Dysfunction

Background: An ankle-brachial index (ABI) value of 0.91–0.99 is considered borderline and associated with an increased risk of cardiovascular events. However, there is no information on the relationship between borderline ABI and endothelial function. Methods and Results: We measured ABI and assesse...

Full description

Saved in:
Bibliographic Details
Published inCirculation Journal Vol. 78; no. 7; pp. 1740 - 1745
Main Authors Hidaka, Takayuki, Maruhashi, Tatsuya, Noma, Kensuke, Kihara, Yasuki, Kajikawa, Masato, Iwamoto, Akimichi, Iwamoto, Yumiko, Nakashima, Ayumu, Matsumoto, Takeshi, Goto, Chikara, Chayama, Kazuaki, Higashi, Yukihito
Format Journal Article
LanguageEnglish
Published Japan The Japanese Circulation Society 2014
Subjects
Online AccessGet full text
ISSN1346-9843
1347-4820
1347-4820
DOI10.1253/circj.CJ-14-0165

Cover

Abstract Background: An ankle-brachial index (ABI) value of 0.91–0.99 is considered borderline and associated with an increased risk of cardiovascular events. However, there is no information on the relationship between borderline ABI and endothelial function. Methods and Results: We measured ABI and assessed vascular function by flow-mediated vasodilation (FMD) and nitroglycerin-induced vasodilation in 389 subjects who underwent health examinations. Subjects were divided into 3 groups according to ABI (normal group: 1.00–1.40, borderline group: 0.91–0.99, abnormal group: ≤0.90 or >1.40). FMD was significantly smaller in both the borderline and the abnormal group than in the normal group. There was no significant difference in the vascular responses to nitroglycerin between the normal and borderline groups. Vascular response to nitroglycerin was significantly higher in the normal group than in the abnormal group. Borderline and abnormal ABI values were significantly associated with an increased odds ratio of low tertile of FMD levels, using the normal ABI group as the reference. Multiple logistic regression analysis for FMD revealed that age, sex, hypertension, diabetes mellitus, and borderline ABI independently remained associated with FMD. Conclusions: ABI of 0.91–0.99 is associated with endothelial dysfunction. ABI examination is a simple and cost-effective method for obtaining the additional information on the initial step of atherosclerosis beyond the assessment of peripheral artery disease.  (Circ J 2014; 78: 1740–1745)
AbstractList An ankle-brachial index (ABI) value of 0.91-0.99 is considered borderline and associated with an increased risk of cardiovascular events. However, there is no information on the relationship between borderline ABI and endothelial function. We measured ABI and assessed vascular function by flow-mediated vasodilation (FMD) and nitroglycerin-induced vasodilation in 389 subjects who underwent health examinations. Subjects were divided into 3 groups according to ABI (normal group: 1.00-1.40, borderline group: 0.91-0.99, abnormal group: ≤0.90 or >1.40). FMD was significantly smaller in both the borderline and the abnormal group than in the normal group. There was no significant difference in the vascular responses to nitroglycerin between the normal and borderline groups. Vascular response to nitroglycerin was significantly higher in the normal group than in the abnormal group. Borderline and abnormal ABI values were significantly associated with an increased odds ratio of low tertile of FMD levels, using the normal ABI group as the reference. Multiple logistic regression analysis for FMD revealed that age, sex, hypertension, diabetes mellitus, and borderline ABI independently remained associated with FMD. ABI of 0.91-0.99 is associated with endothelial dysfunction. ABI examination is a simple and cost-effective method for obtaining the additional information on the initial step of atherosclerosis beyond the assessment of peripheral artery disease.
An ankle-brachial index (ABI) value of 0.91-0.99 is considered borderline and associated with an increased risk of cardiovascular events. However, there is no information on the relationship between borderline ABI and endothelial function.BACKGROUNDAn ankle-brachial index (ABI) value of 0.91-0.99 is considered borderline and associated with an increased risk of cardiovascular events. However, there is no information on the relationship between borderline ABI and endothelial function.We measured ABI and assessed vascular function by flow-mediated vasodilation (FMD) and nitroglycerin-induced vasodilation in 389 subjects who underwent health examinations. Subjects were divided into 3 groups according to ABI (normal group: 1.00-1.40, borderline group: 0.91-0.99, abnormal group: ≤0.90 or >1.40). FMD was significantly smaller in both the borderline and the abnormal group than in the normal group. There was no significant difference in the vascular responses to nitroglycerin between the normal and borderline groups. Vascular response to nitroglycerin was significantly higher in the normal group than in the abnormal group. Borderline and abnormal ABI values were significantly associated with an increased odds ratio of low tertile of FMD levels, using the normal ABI group as the reference. Multiple logistic regression analysis for FMD revealed that age, sex, hypertension, diabetes mellitus, and borderline ABI independently remained associated with FMD.METHODS AND RESULTSWe measured ABI and assessed vascular function by flow-mediated vasodilation (FMD) and nitroglycerin-induced vasodilation in 389 subjects who underwent health examinations. Subjects were divided into 3 groups according to ABI (normal group: 1.00-1.40, borderline group: 0.91-0.99, abnormal group: ≤0.90 or >1.40). FMD was significantly smaller in both the borderline and the abnormal group than in the normal group. There was no significant difference in the vascular responses to nitroglycerin between the normal and borderline groups. Vascular response to nitroglycerin was significantly higher in the normal group than in the abnormal group. Borderline and abnormal ABI values were significantly associated with an increased odds ratio of low tertile of FMD levels, using the normal ABI group as the reference. Multiple logistic regression analysis for FMD revealed that age, sex, hypertension, diabetes mellitus, and borderline ABI independently remained associated with FMD.ABI of 0.91-0.99 is associated with endothelial dysfunction. ABI examination is a simple and cost-effective method for obtaining the additional information on the initial step of atherosclerosis beyond the assessment of peripheral artery disease.CONCLUSIONSABI of 0.91-0.99 is associated with endothelial dysfunction. ABI examination is a simple and cost-effective method for obtaining the additional information on the initial step of atherosclerosis beyond the assessment of peripheral artery disease.
Background: An ankle-brachial index (ABI) value of 0.91–0.99 is considered borderline and associated with an increased risk of cardiovascular events. However, there is no information on the relationship between borderline ABI and endothelial function. Methods and Results: We measured ABI and assessed vascular function by flow-mediated vasodilation (FMD) and nitroglycerin-induced vasodilation in 389 subjects who underwent health examinations. Subjects were divided into 3 groups according to ABI (normal group: 1.00–1.40, borderline group: 0.91–0.99, abnormal group: ≤0.90 or >1.40). FMD was significantly smaller in both the borderline and the abnormal group than in the normal group. There was no significant difference in the vascular responses to nitroglycerin between the normal and borderline groups. Vascular response to nitroglycerin was significantly higher in the normal group than in the abnormal group. Borderline and abnormal ABI values were significantly associated with an increased odds ratio of low tertile of FMD levels, using the normal ABI group as the reference. Multiple logistic regression analysis for FMD revealed that age, sex, hypertension, diabetes mellitus, and borderline ABI independently remained associated with FMD. Conclusions: ABI of 0.91–0.99 is associated with endothelial dysfunction. ABI examination is a simple and cost-effective method for obtaining the additional information on the initial step of atherosclerosis beyond the assessment of peripheral artery disease.  (Circ J 2014; 78: 1740–1745)
Author Nakashima, Ayumu
Goto, Chikara
Matsumoto, Takeshi
Hidaka, Takayuki
Iwamoto, Akimichi
Kihara, Yasuki
Noma, Kensuke
Chayama, Kazuaki
Maruhashi, Tatsuya
Higashi, Yukihito
Kajikawa, Masato
Iwamoto, Yumiko
Author_xml – sequence: 1
  fullname: Hidaka, Takayuki
  organization: Department of Cardiovascular Medicine, Institute of Biomedical & Health Sciences
– sequence: 1
  fullname: Maruhashi, Tatsuya
  organization: Department of Cardiovascular Medicine, Institute of Biomedical & Health Sciences
– sequence: 1
  fullname: Noma, Kensuke
  organization: Division of Regeneration and Medicine, Medical Center for Translational and Clinical Research, Hiroshima University Hospital
– sequence: 1
  fullname: Kihara, Yasuki
  organization: Department of Cardiovascular Medicine, Institute of Biomedical & Health Sciences
– sequence: 1
  fullname: Kajikawa, Masato
  organization: Department of Cardiovascular Medicine, Institute of Biomedical & Health Sciences
– sequence: 1
  fullname: Iwamoto, Akimichi
  organization: Department of Cardiovascular Medicine, Institute of Biomedical & Health Sciences
– sequence: 1
  fullname: Iwamoto, Yumiko
  organization: Department of Cardiovascular Medicine, Institute of Biomedical & Health Sciences
– sequence: 1
  fullname: Nakashima, Ayumu
  organization: Division of Regeneration and Medicine, Medical Center for Translational and Clinical Research, Hiroshima University Hospital
– sequence: 1
  fullname: Matsumoto, Takeshi
  organization: Department of Cardiovascular Medicine, Institute of Biomedical & Health Sciences
– sequence: 1
  fullname: Goto, Chikara
  organization: Hiroshima International University
– sequence: 1
  fullname: Chayama, Kazuaki
  organization: Department of Gastroenterology and Metabolism, Applied Life Science, Institute of Biomedical & Health Sciences
– sequence: 1
  fullname: Higashi, Yukihito
  organization: Division of Regeneration and Medicine, Medical Center for Translational and Clinical Research, Hiroshima University Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24813179$$D View this record in MEDLINE/PubMed
BookMark eNp9kM1uEzEUhS1U1P89KzRLNhPssWdsL9P0h1SV2ABdWo7nDnFw7GB7BNnxDrxhn4SZJrQICaSre2zpfPdI5wQd-OABoVcET0hV07fGRrOazG5LwkpMmvoFOiaU8ZKJCh88vptSCkaP0ElKK4wriWt5iI4qJgglXB4jdRFiC9FZD8XUf3FQXkRtlla7Yu5b-F580q6HInQFnkjy8OPnILKYp2KaUjBWZ2iLe5uXxZVvQ16CG8nLbep6b7IN_gy97LRLcL7XU_Tx-urD7F159_5mPpvelYZJlktRwwIM1Y0g2khhsBSNwAbDoNAuNO5aYnQlaIcbySssZN3winNDhx8XDT1FZHe39xu9_aadU5to1zpuFcFqLEs9lqWGIUyNZQ3Mmx2zieFrDymrtU0GnNMeQp8UqRmhnAgpB-vrvbVfrKF9uv27yMGAdwYTQ0oRun_Ez27_iG_-QozNeiwtR23d_8DrHbhKWX-GpyQdszUO9gAXio_rGXw2LHVU4Okvel2xcQ
CitedBy_id crossref_primary_10_1186_s40942_023_00521_5
crossref_primary_10_1253_circj_CJ_16_0017
crossref_primary_10_1161_HYPERTENSIONAHA_115_06839
crossref_primary_10_25259_mm_ijcdw_417
crossref_primary_10_1177_00033197241226512
crossref_primary_10_4103_1879_5226_249330
crossref_primary_10_1016_j_ijcard_2016_09_123
crossref_primary_10_3390_jcm14051625
crossref_primary_10_15829_1728_8800_2019_6_136_141
crossref_primary_10_1253_circj_CJ_16_0164
crossref_primary_10_1016_j_acmx_2018_02_009
crossref_primary_10_5551_jat_64639
crossref_primary_10_4082_kjfm_17_0035
crossref_primary_10_1024_0301_1526_a001131
crossref_primary_10_1111_iju_13336
crossref_primary_10_2169_internalmedicine_5401_20
crossref_primary_10_1038_s41598_024_64118_0
crossref_primary_10_3389_fendo_2017_00333
crossref_primary_10_1016_j_atherosclerosis_2016_05_014
crossref_primary_10_1186_s12889_018_5263_6
crossref_primary_10_5758_vsi_200012
crossref_primary_10_1253_circj_CJ_15_0552
crossref_primary_10_4093_dmj_2018_42_1_63
crossref_primary_10_1253_circj_CJ_15_1356
Cites_doi 10.1253/circj.CJ-13-1330
10.1001/jama.285.19.2486
10.1161/01.CIR.0000095273.92468.D9
10.1161/CIRCULATIONAHA.105.593442
10.1016/j.jns.2008.08.016
10.1056/NEJM199901143400207
10.1161/01.CIR.0000153339.27064.14
10.1001/jama.2012.13415
10.1253/circj.CJ-12-1087
10.1253/circj.CJ-08-1102
10.1161/CIRCULATIONAHA.109.864801
10.1111/j.1532-5415.2008.01633.x
10.1161/01.ATV.0000168911.78624.b7
10.1161/CIRCULATIONAHA.109.865600
10.1161/ATVBAHA.111.227892
10.1016/S0735-1097(98)00206-X
10.1161/HYPERTENSIONAHA.110.163683
10.1016/j.jacc.2010.04.060
10.1016/0140-6736(92)93147-F
10.1016/S0735-1097(02)01976-9
10.1038/clpt.2011.227
10.2337/diacare.22.1.1
10.1161/01.CIR.0000112642.63927.54
10.1161/CIR.0b013e31822e80c3
10.1001/jama.300.2.197
10.1161/01.CIR.0000012543.55874.47
10.1016/0735-1097(94)90141-4
10.1161/CIR.0b013e318276fbcb
10.1161/ATVBAHA.112.300934
10.1016/j.atherosclerosis.2004.08.013
10.1097/00005344-200205000-00007
10.1161/01.CIR.0000112565.60887.1E
10.1016/S0002-9149(00)01321-7
10.1016/j.amjcard.2006.05.056
10.1161/ATVBAHA.112.249680
ContentType Journal Article
Copyright 2014 THE JAPANESE CIRCULATION SOCIETY
Copyright_xml – notice: 2014 THE JAPANESE CIRCULATION SOCIETY
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ADTOC
UNPAY
DOI 10.1253/circj.CJ-14-0165
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Unpaywall for CDI: Periodical Content
Unpaywall
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1347-4820
EndPage 1745
ExternalDocumentID 10.1253/circj.cj-14-0165
24813179
10_1253_circj_CJ_14_0165
article_circj_78_7_78_CJ_14_0165_article_char_en
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.55
.GJ
29B
2WC
3O-
53G
5GY
5RE
6J9
ACGFO
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
GX1
JSF
JSH
KQ8
OK1
OVT
P2P
RJT
RNS
RZJ
TKC
TR2
W2D
X7M
XSB
ZXP
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
M~E
NPM
RYR
7X8
ADTOC
UNPAY
ID FETCH-LOGICAL-c494t-85ebec3a681ac98c098680c0e986edba0fd1ca283f06972089567277c39727863
IEDL.DBID UNPAY
ISSN 1346-9843
1347-4820
IngestDate Tue Aug 19 21:27:57 EDT 2025
Thu Oct 02 12:02:57 EDT 2025
Thu May 23 23:48:27 EDT 2024
Tue Jul 01 02:01:12 EDT 2025
Thu Apr 24 23:00:35 EDT 2025
Wed Sep 03 06:24:09 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c494t-85ebec3a681ac98c098680c0e986edba0fd1ca283f06972089567277c39727863
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://proxy.k.utb.cz/login?url=https://www.jstage.jst.go.jp/article/circj/78/7/78_CJ-14-0165/_pdf
PMID 24813179
PQID 1541371899
PQPubID 23479
PageCount 6
ParticipantIDs unpaywall_primary_10_1253_circj_cj_14_0165
proquest_miscellaneous_1541371899
pubmed_primary_24813179
crossref_primary_10_1253_circj_CJ_14_0165
crossref_citationtrail_10_1253_circj_CJ_14_0165
jstage_primary_article_circj_78_7_78_CJ_14_0165_article_char_en
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-00-00
PublicationDateYYYYMMDD 2014-01-01
PublicationDate_xml – year: 2014
  text: 2014-00-00
PublicationDecade 2010
PublicationPlace Japan
PublicationPlace_xml – name: Japan
PublicationTitle Circulation Journal
PublicationTitleAlternate Circ J
PublicationYear 2014
Publisher The Japanese Circulation Society
Publisher_xml – name: The Japanese Circulation Society
References 12. Modena MG, Bonetti L, Coppi F, Bursi F, Rossi R. Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J Am Coll Cardiol 2002; 40: 505–510.
20. McDermott MM, Tian L, Ferrucci L, Liu K, Guralnik JM, Liao Y, et al. Associations between lower extremity ischemia, upper and lower extremity strength, and functional impairment with peripheral arterial disease. J Am Geriatr Soc 2008; 56: 724–729.
2. Higashi Y, Noma K, Yoshizumi M, Kihara Y. Oxidative stress and endothelial function in cardiovascular diseases (Review). Circ J 2009; 73: 411–418.
29. Iwamoto Y, Maruhashi T, Fujii Y, Idei N, Fujimura N, Mikami S, et al. Intima-media thickness of brachial artery, endothelial function, and cardiovascular risk factors. Arterioscler Thromb Vasc Biol 2012; 32: 2295–2303.
16. Yeboah J, Folsom AR, Burke GL, Johnson C, Polak JF, Post W, et al. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: The multi-ethnic study of atherosclerosis. Circulation 2009; 120: 502–509.
19. Diehm C, Allenberg JR, Pittrow D, Mahn M, Tepohl G, Haberl RL, et al. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation 2009; 120: 2053–2061.
33. Joosten MM, Pai JK, Bertoia ML, Rimm EB, Spiegelman D, Mittleman MA, et al. Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men. JAMA 2012; 308: 1660–1667.
8. Fujimura N, Noma K, Hata T, Hidaka T, Idei N, Fujii Y, et al. Mineralocorticoid receptor blocker eplerenone improves endothelial function and inhibits Rho-associated kinase activity in patients with hypertension. Clin Pharmacol Ther 2012; 91: 289–297.
11. Raitakari OT, Seale JP, Celermajer DS. Impaired vascular responses to nitroglycerin in subjects with coronary atherosclerosis. Am J Cardiol 2001; 87: 217–219, A8.
26. Ovbiagele B. Association of ankle-brachial index level with stroke. J Neurol Sci 2009; 276: 14–17.
35. Criqui MH, McClelland RL, McDermott MM, Allison MA, Blumenthal RS, Aboyans V, et al. The ankle-brachial index and incident cardiovascular events in the MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2010; 56: 1506–1512.
1. Ross R. Atherosclerosis: An inflammatory disease. N Engl J Med 1999; 340: 115–126.
15. Lerman A, Zeiher AM. Endothelial function: Cardiac events. Circulation 2005; 111: 363–368.
18. Golomb BA, Dang TT, Criqui MH. Peripheral arterial disease: Morbidity and mortality implications. Circulation 2006; 114: 688–699.
5. Benjamin EJ, Larson MG, Keyes MJ, Mitchell GF, Vasan RS, Keaney JF Jr, et al. Clinical correlates and heritability of flow-mediated dilation in the community: The Framingham Heart Study. Circulation 2004; 109: 613–619.
28. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497.
22. Aboyans V, Criqui MH, Abraham P, Allison MA, Creager MA, Diehm C, et al. Measurement and interpretation of the ankle-brachial index: A scientific statement from the American Heart Association. Circulation 2012; 126: 2890–2909.
17. Doobay AV, Anand SS. Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: A systematic review. Arterioscler Thromb Vasc Biol 2005; 25: 1463–1469.
4. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994; 24: 1468–1474.
3. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111–1115.
32. Sanada H, Higashi Y, Goto C, Chayama K, Yoshizumi M, Sueda T. Vascular function in patients with lower extremity peripheral arterial disease: A comparison of functions in upper and lower extremities. Atherosclerosis 2005; 178: 179–185.
9. Kajikawa M, Nakashima A, Maruhashi T, Iwamoto Y, Iwamoto A, Matsumoto T, et al. Poor oral health, that is, Decreased frequency of tooth brushing, is associated with endothelial dysfunction. Circ J 2014; 78: 950–954.
27. American Diabetes Association. Clinical practice recommendations 1999. Diabetes Care 1999; 22(Suppl 1): S1–S114.
30. Higashi Y, Sasaki S, Nakagawa K, Kimura M, Sasaki S, Noma K, et al. The severity of hypertension affects improved resistance artery endothelial function by angiotensin converting enzyme inhibition. J Cardiovasc Pharmacol 2002; 39: 668–676.
10. Adams MR, Robinson J, McCredie R, Seale JP, Sorensen KE, Deanfield JE, et al. Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis. J Am Coll Cardiol 1998; 32: 123–127.
7. Soga J, Noma K, Hata T, Hidaka T, Fujii Y, Idei N, et al. Rho-associated kinase activity, endothelial function, and cardiovascular risk factors. Arterioscler Thromb Vasc Biol 2011; 31: 2353–2359.
6. Idei N, Nishioka K, Soga J, Hidaka T, Hata T, Fujii Y, et al. Vascular function and circulating progenitor cells in thromboangitis obliterans (Buerger’s disease) and atherosclerosis obliterans. Hypertension 2011; 57: 70–78.
31. Maruhashi T, Soga J, Fujimura N, Idei N, Mikami S, Iwamoto Y, et al. Nitroglycerine-induced vasodilation for assessment of vascular function: A comparison with flow-mediated vasodilation. Arterioscler Thromb Vasc Biol 2013; 33: 1401–1408.
23. Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss LK, et al. 2011 ACCF/AHA Focused Update of the Guideline for the Management of patients with peripheral artery disease (Updating the 2005 Guideline): A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2011; 124: 2020–2045.
14. Brevetti G, Silvestro A, Schiano V, Chiariello M. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: Additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation 2003; 108: 2093–2098.
34. Resnick HE, Lindsay RS, McDermott MM, Devereux RB, Jones KL, Fabsitz RR, et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: The Strong Heart Study. Circulation 2004; 109: 733–739.
21. Ikeda N, Kogame N, Iijima R, Nakamura M, Sugi K. Impact of carotid artery ultrasound and ankle-brachial index on prediction of severity of SYNTAX score. Circ J 2013; 77: 712–716.
25. Ankle Brachial Index Collaboration, Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: A meta-analysis. JAMA 2008; 300: 197–208.
13. Gokce N, Keaney JF Jr, Hunter LM, Watkins MT, Menzoian JO, Vita JA. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: A prospective study. Circulation 2002; 105: 1567–1572.
24. Menke A, Muntner P, Wildman RP, Dreisbach AW, Raggi P. Relation of borderline peripheral arterial disease to cardiovascular disease risk. Am J Cardiol 2006; 98: 1226–1230.
22
23
24
25
26
27
28
29
30
31
10
32
11
33
12
34
13
35
14
15
16
17
18
19
1
2
3
4
5
6
7
8
9
20
21
References_xml – reference: 19. Diehm C, Allenberg JR, Pittrow D, Mahn M, Tepohl G, Haberl RL, et al. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation 2009; 120: 2053–2061.
– reference: 29. Iwamoto Y, Maruhashi T, Fujii Y, Idei N, Fujimura N, Mikami S, et al. Intima-media thickness of brachial artery, endothelial function, and cardiovascular risk factors. Arterioscler Thromb Vasc Biol 2012; 32: 2295–2303.
– reference:  6. Idei N, Nishioka K, Soga J, Hidaka T, Hata T, Fujii Y, et al. Vascular function and circulating progenitor cells in thromboangitis obliterans (Buerger’s disease) and atherosclerosis obliterans. Hypertension 2011; 57: 70–78.
– reference:  5. Benjamin EJ, Larson MG, Keyes MJ, Mitchell GF, Vasan RS, Keaney JF Jr, et al. Clinical correlates and heritability of flow-mediated dilation in the community: The Framingham Heart Study. Circulation 2004; 109: 613–619.
– reference: 12. Modena MG, Bonetti L, Coppi F, Bursi F, Rossi R. Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J Am Coll Cardiol 2002; 40: 505–510.
– reference: 15. Lerman A, Zeiher AM. Endothelial function: Cardiac events. Circulation 2005; 111: 363–368.
– reference: 31. Maruhashi T, Soga J, Fujimura N, Idei N, Mikami S, Iwamoto Y, et al. Nitroglycerine-induced vasodilation for assessment of vascular function: A comparison with flow-mediated vasodilation. Arterioscler Thromb Vasc Biol 2013; 33: 1401–1408.
– reference: 13. Gokce N, Keaney JF Jr, Hunter LM, Watkins MT, Menzoian JO, Vita JA. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: A prospective study. Circulation 2002; 105: 1567–1572.
– reference: 32. Sanada H, Higashi Y, Goto C, Chayama K, Yoshizumi M, Sueda T. Vascular function in patients with lower extremity peripheral arterial disease: A comparison of functions in upper and lower extremities. Atherosclerosis 2005; 178: 179–185.
– reference:  2. Higashi Y, Noma K, Yoshizumi M, Kihara Y. Oxidative stress and endothelial function in cardiovascular diseases (Review). Circ J 2009; 73: 411–418.
– reference: 30. Higashi Y, Sasaki S, Nakagawa K, Kimura M, Sasaki S, Noma K, et al. The severity of hypertension affects improved resistance artery endothelial function by angiotensin converting enzyme inhibition. J Cardiovasc Pharmacol 2002; 39: 668–676.
– reference:  1. Ross R. Atherosclerosis: An inflammatory disease. N Engl J Med 1999; 340: 115–126.
– reference: 11. Raitakari OT, Seale JP, Celermajer DS. Impaired vascular responses to nitroglycerin in subjects with coronary atherosclerosis. Am J Cardiol 2001; 87: 217–219, A8.
– reference: 26. Ovbiagele B. Association of ankle-brachial index level with stroke. J Neurol Sci 2009; 276: 14–17.
– reference: 33. Joosten MM, Pai JK, Bertoia ML, Rimm EB, Spiegelman D, Mittleman MA, et al. Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men. JAMA 2012; 308: 1660–1667.
– reference:  4. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994; 24: 1468–1474.
– reference: 25. Ankle Brachial Index Collaboration, Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: A meta-analysis. JAMA 2008; 300: 197–208.
– reference:  9. Kajikawa M, Nakashima A, Maruhashi T, Iwamoto Y, Iwamoto A, Matsumoto T, et al. Poor oral health, that is, Decreased frequency of tooth brushing, is associated with endothelial dysfunction. Circ J 2014; 78: 950–954.
– reference: 27. American Diabetes Association. Clinical practice recommendations 1999. Diabetes Care 1999; 22(Suppl 1): S1–S114.
– reference: 18. Golomb BA, Dang TT, Criqui MH. Peripheral arterial disease: Morbidity and mortality implications. Circulation 2006; 114: 688–699.
– reference:  3. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111–1115.
– reference: 20. McDermott MM, Tian L, Ferrucci L, Liu K, Guralnik JM, Liao Y, et al. Associations between lower extremity ischemia, upper and lower extremity strength, and functional impairment with peripheral arterial disease. J Am Geriatr Soc 2008; 56: 724–729.
– reference: 14. Brevetti G, Silvestro A, Schiano V, Chiariello M. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: Additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation 2003; 108: 2093–2098.
– reference:  8. Fujimura N, Noma K, Hata T, Hidaka T, Idei N, Fujii Y, et al. Mineralocorticoid receptor blocker eplerenone improves endothelial function and inhibits Rho-associated kinase activity in patients with hypertension. Clin Pharmacol Ther 2012; 91: 289–297.
– reference: 23. Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss LK, et al. 2011 ACCF/AHA Focused Update of the Guideline for the Management of patients with peripheral artery disease (Updating the 2005 Guideline): A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2011; 124: 2020–2045.
– reference: 28. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497.
– reference: 21. Ikeda N, Kogame N, Iijima R, Nakamura M, Sugi K. Impact of carotid artery ultrasound and ankle-brachial index on prediction of severity of SYNTAX score. Circ J 2013; 77: 712–716.
– reference: 35. Criqui MH, McClelland RL, McDermott MM, Allison MA, Blumenthal RS, Aboyans V, et al. The ankle-brachial index and incident cardiovascular events in the MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2010; 56: 1506–1512.
– reference:  7. Soga J, Noma K, Hata T, Hidaka T, Fujii Y, Idei N, et al. Rho-associated kinase activity, endothelial function, and cardiovascular risk factors. Arterioscler Thromb Vasc Biol 2011; 31: 2353–2359.
– reference: 16. Yeboah J, Folsom AR, Burke GL, Johnson C, Polak JF, Post W, et al. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: The multi-ethnic study of atherosclerosis. Circulation 2009; 120: 502–509.
– reference: 17. Doobay AV, Anand SS. Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: A systematic review. Arterioscler Thromb Vasc Biol 2005; 25: 1463–1469.
– reference: 22. Aboyans V, Criqui MH, Abraham P, Allison MA, Creager MA, Diehm C, et al. Measurement and interpretation of the ankle-brachial index: A scientific statement from the American Heart Association. Circulation 2012; 126: 2890–2909.
– reference: 24. Menke A, Muntner P, Wildman RP, Dreisbach AW, Raggi P. Relation of borderline peripheral arterial disease to cardiovascular disease risk. Am J Cardiol 2006; 98: 1226–1230.
– reference: 10. Adams MR, Robinson J, McCredie R, Seale JP, Sorensen KE, Deanfield JE, et al. Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis. J Am Coll Cardiol 1998; 32: 123–127.
– reference: 34. Resnick HE, Lindsay RS, McDermott MM, Devereux RB, Jones KL, Fabsitz RR, et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: The Strong Heart Study. Circulation 2004; 109: 733–739.
– ident: 9
  doi: 10.1253/circj.CJ-13-1330
– ident: 28
  doi: 10.1001/jama.285.19.2486
– ident: 14
  doi: 10.1161/01.CIR.0000095273.92468.D9
– ident: 18
  doi: 10.1161/CIRCULATIONAHA.105.593442
– ident: 26
  doi: 10.1016/j.jns.2008.08.016
– ident: 1
  doi: 10.1056/NEJM199901143400207
– ident: 15
  doi: 10.1161/01.CIR.0000153339.27064.14
– ident: 33
  doi: 10.1001/jama.2012.13415
– ident: 21
  doi: 10.1253/circj.CJ-12-1087
– ident: 2
  doi: 10.1253/circj.CJ-08-1102
– ident: 16
  doi: 10.1161/CIRCULATIONAHA.109.864801
– ident: 20
  doi: 10.1111/j.1532-5415.2008.01633.x
– ident: 17
  doi: 10.1161/01.ATV.0000168911.78624.b7
– ident: 19
  doi: 10.1161/CIRCULATIONAHA.109.865600
– ident: 7
  doi: 10.1161/ATVBAHA.111.227892
– ident: 10
  doi: 10.1016/S0735-1097(98)00206-X
– ident: 6
  doi: 10.1161/HYPERTENSIONAHA.110.163683
– ident: 35
  doi: 10.1016/j.jacc.2010.04.060
– ident: 3
  doi: 10.1016/0140-6736(92)93147-F
– ident: 12
  doi: 10.1016/S0735-1097(02)01976-9
– ident: 8
  doi: 10.1038/clpt.2011.227
– ident: 27
  doi: 10.2337/diacare.22.1.1
– ident: 34
  doi: 10.1161/01.CIR.0000112642.63927.54
– ident: 23
  doi: 10.1161/CIR.0b013e31822e80c3
– ident: 25
  doi: 10.1001/jama.300.2.197
– ident: 13
  doi: 10.1161/01.CIR.0000012543.55874.47
– ident: 4
  doi: 10.1016/0735-1097(94)90141-4
– ident: 22
  doi: 10.1161/CIR.0b013e318276fbcb
– ident: 31
  doi: 10.1161/ATVBAHA.112.300934
– ident: 32
  doi: 10.1016/j.atherosclerosis.2004.08.013
– ident: 30
  doi: 10.1097/00005344-200205000-00007
– ident: 5
  doi: 10.1161/01.CIR.0000112565.60887.1E
– ident: 11
  doi: 10.1016/S0002-9149(00)01321-7
– ident: 24
  doi: 10.1016/j.amjcard.2006.05.056
– ident: 29
  doi: 10.1161/ATVBAHA.112.249680
SSID ssj0029059
Score 2.2035036
Snippet Background: An ankle-brachial index (ABI) value of 0.91–0.99 is considered borderline and associated with an increased risk of cardiovascular events. However,...
An ankle-brachial index (ABI) value of 0.91-0.99 is considered borderline and associated with an increased risk of cardiovascular events. However, there is no...
SourceID unpaywall
proquest
pubmed
crossref
jstage
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1740
SubjectTerms Adult
Aged
Ankle Brachial Index - methods
Ankle-brachial index
Endothelial function
Female
Humans
Intima-media thickness
Male
Middle Aged
Nitroglycerin - administration & dosage
Peripheral Arterial Disease - diagnosis
Peripheral Arterial Disease - physiopathology
Peripheral artery disease
Tunica Intima - physiopathology
Vascular smooth muscle function
Vasodilation
Vasodilator Agents - administration & dosage
Title Borderline Ankle-Brachial Index Value of 0.91–0.99 Is Associated With Endothelial Dysfunction
URI https://www.jstage.jst.go.jp/article/circj/78/7/78_CJ-14-0165/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/24813179
https://www.proquest.com/docview/1541371899
https://www.jstage.jst.go.jp/article/circj/78/7/78_CJ-14-0165/_pdf
UnpaywallVersion publishedVersion
Volume 78
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Circulation Journal, 2014, Vol.78(7), pp.1740-1745
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1347-4820
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0029059
  issn: 1347-4820
  databaseCode: KQ8
  dateStart: 20020101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1347-4820
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0029059
  issn: 1347-4820
  databaseCode: DIK
  dateStart: 20020101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1347-4820
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0029059
  issn: 1347-4820
  databaseCode: GX1
  dateStart: 0
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7RLYJy4E1ZHlWQuIDkPJ3YPqFtaWkrUXFgYXuyHMfbNo2yq91EqJz4D_xDfgnjPJaCAAlxiQ-Z8WvGmW_i8RjgOY9DhXaAkjQyGaFpxoliqSCBMcIIu7pMk-3zKNkf08NJPLl0FsaGVeaIi06MLdyTmZvPvW4SPX220LnHuMfwIXcOSWAjKJLYk_NsugbrSYx4fADr46N3o-PG06IJEbyNso8oIxTtXbdXGcZRW5-r876en2zT1bYbv0OeN-B6Xc7VxSdVFJes0d4t0P042iCUc7euUld__iXF4_8N9Dbc7MCqM2rp78AVU96Fa2-77fh7ILebzJ0WqTqj8rwwZHthgzOR58BmYXQ-qKI2zmzq-K4Ivn35ioVwDpZOrxQmcz6eVafObpnZk2CF5Xx9sbTG1irMfRjv7b7f2SfdjQ1EU0ErwmOrE5FKeKC04NoXPOG-9g2WJkuVP80CrRDRTP1EsNDn6J0hgGIaUVHIeBI9gEE5K81DcBB3-YLhe3tHL1NUoYmNWJSoMOUhYrwheL2spO7SmdtbNQpp3RqUrmwmEScPvRtpJ28IL1Yc8zaVx19oX7XCWVF2oukoUSpMNqLpOX4QnKoFfnKG8KzXG4kr1m7DqNLM6qVE0BpECAmEGMJmq1CrVkLKA0R0-OblSsP-0Fmd900_-hfix7CBmI-2f5GewKBa1OYp4qoq3YK1N5Ngq1s-3wF3nx9F
linkProvider Unpaywall
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7BFvE48H4sLxmJC0jO04ntE9qWVm0lKg4slJPlON62aZRd7SZC5cR_4B_ySxjnsRQESIhLfMiMXzPOfBOPxwDPRRJptAOMZrHNKctyQTXPJA2tlVa61WXbbJ8H6e6U7R8mh-fOwriwygJx0ZF1hXc094qF30-ib06WpvC58Dk-1NY-DV0ERZr4apHPLsJGmiAeH8HG9ODt5GPrabGUStFF2ceMU4b2rt-rjJK4q88zxVDPT7bpUteN3yHPa3ClqRb67JMuy3PWaOcGmGEcXRDKqdfUmWc-_5Li8f8GehOu92CVTDr6W3DBVrfh8pt-O_4OqM02c6dDqmRSnZaWbi5dcCby7LksjOS9LhtL5jMSeDL89uUrFpLsrcigFDYnH07qY7Jd5e4kWOk4X5-tnLF1CnMXpjvb77Z2aX9jAzVMspqKxOlErFMRaiOFCaRIRWACi6XNMx3M8tBoRDSzIJU8CgR6ZwiguEFUFHGRxvdgVM0r-wAI4q5Acnzv7ujlmmk0sTGPUx1lIkKMNwZ_kJUyfTpzd6tGqZxbg9JV7STi5KF3o9zkjeHFmmPRpfL4C-2rTjhryl40PSVKhatWNAPHD4JjvcRPzhieDXqjcMW6bRhd2XmzUghawxghgZRjuN8p1LqViIkQER2-ebnWsD901hRD0w__hfgRXEXMx7q_SI9hVC8b-wRxVZ097RfOd8G6HlQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Borderline+Ankle-Brachial+Index+Value+of+0.91%E2%80%930.99+Is+Associated+With+Endothelial+Dysfunction&rft.jtitle=Circulation+Journal&rft.au=Hidaka%2C+Takayuki&rft.au=Maruhashi%2C+Tatsuya&rft.au=Noma%2C+Kensuke&rft.au=Kihara%2C+Yasuki&rft.date=2014&rft.pub=The+Japanese+Circulation+Society&rft.issn=1346-9843&rft.eissn=1347-4820&rft.volume=78&rft.issue=7&rft.spage=1740&rft.epage=1745&rft_id=info:doi/10.1253%2Fcircj.CJ-14-0165&rft.externalDocID=article_circj_78_7_78_CJ_14_0165_article_char_en
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1346-9843&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1346-9843&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1346-9843&client=summon